Navigation Links
China Medicine Corporation Obtains Australian Patent for rADTZ
Date:7/17/2008

GUANGZHOU, China, July 17 /Xinhua-PRNewswire/ -- China Medicine Corporation (OTC Bulletin Board: CHME; "China Medicine" or "the Company"), a leading distributor and developer of ethical and over-the-counter drugs, traditional Chinese medicines (TCMs), nutritional and dietary supplements, medical devices, and medical formulations in the People's Republic of China (PRC), announced today that it obtained a patent from Australia Patent Office for recombinant Aflatoxin Detoxifizyme (rADTZ). The patent is valid through January 13, 2025.

rADTZ is an innovative product that has the potential to detoxify aflatoxin (AFT), a potential cancer causing agent, in food and feed. It is a compound that is a derivation of aflatoxin-detoxifizyme (ADTZ), an extracellular enzyme. Developed by Guangzhou Co-Win Bioengineering Co., Ltd, a subsidiary of China Medicine, rADTZ can be used as an additive to remove aflatoxins from animal feed as well as other food products. The Company intends to develop rADTZ for this and other applications.

"We are proud to announce that we have achieved a major milestone in being granted a patent for rADTZ in Australia," said Mr. Senshan Yang, Chairman and CEO of China Medicine. "This is a major breakthrough for China Medicine and it opens up the opportunity to expand our business overseas," he added. China Medicine has already obtained a patent for rADTZ from the State Intellectual Property Office of China in early 2004.

China Medicine has performed laboratory experiment on rADTZ and has gathered important data to address technological challenges related to its development. The Company is currently testing rADTZ on animal feed and is scheduled to begin working with the Chinese Department of Agriculture on a large scale experiment in order to meet national standards and apply for production permits. Once the Company receives production permits, it expects to begin trial sales of rADTZ by the end of 2008.

About China Medicine Corporation

China Medicine Corporation is a leading pharmaceutical company which discovers and develops medical formulations and distributes over 2,200 pharmaceutical products in China including prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary supplements. The Company distributes the products to wholesale distributors in 28 provinces, more than 300 hospitals, 500 medicine companies, and 1,788 drug stores throughout China. The Company actively develops a number of proprietary products for many uses including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com .

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward- looking statements to reflect events or circumstances after the date of this release.

For more information, please contact:

Company Contact:

Ms. Huizhen Yu

Chief Financial Officer

China Medicine Corp.

Tel: +86-20-8739-1718

Email: konzern08@163.com

Web: http://www.chinamedicinecorp.com

Investor Relations Contact:

Mr. Crocker Coulson, President

CCG Investor Relations

Tel: +1-646-213-1915 (New York)

Email: crocker.coulson@ccgir.com

Mr. Richard Micchelli, Financial Writer

Tel: +1-646-454-4516

Email: richard.micchelli@ccgir.com

Web: http://www.ccgir.com


'/>"/>
SOURCE China Medicine Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. Signs Distribution Agreement with Harbin Baolong Pharmaceutical Company
2. AmeriCares Purchases 2nd BLU-MED Deployable Field Hospital for China Earthquake Relief
3. Closing coal-burning power plant in China and improved cognitive development in children
4. China Kangtai Cactus Biotech Inc. Launches Cactus Cattle Feed and Cactus Fish Feed
5. AmeriCares Meets Long-Term Health Needs of Disaster Victims in China and Myanmar
6. Chindexs United Family Healthcare Launches ChinaHealthWatch.org - A global resource for travelers to China
7. China Medicine Releases White Paper on Developing Recombinant Aflatoxin-Detoxifizyme
8. Chindex International, Inc. Announces Receipt of Key Regulatory ApprovalsChina SFDA Certificates Received Include Intuitive Surgical daVinci S
9. China Improves Safety Management on Imported Foods in Preparation for Olympic Games
10. AMDL Signs Letter of Intent to Purchase China-Based Pharmaceutical Distribution Company
11. Cynosure Expands Presence in China with the Opening of Sales Office in Beijing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Access today ... Exhibition in Orlando, Fla., February 19-23. Visitors to the company’s booth (#1778) will ... used electronic patient signatures solution in healthcare . , Since it first ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Officer, George Rogers, was named to Staffing Industry Analysts' 2017 "Staffing 100 North ... those who have made notable contributions to the staffing industry over the last ...
(Date:2/17/2017)... , ... February 17, 2017 , ... Like most hospitals ... readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), the return ... key focus area for hospitals across the nation. While many providers are struggling to ...
(Date:2/17/2017)... ... February 17, 2017 , ... The Mason Pasquin Agency, a ... business owners in and around the Hampton Roads metropolitan region, is joining the ... of domestic violence. , There are multiple categories of domestic violence – physical ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... NEW YORK , February 17, 2017 ... Composite and the S&P 500 edged lower at the ... its bullish streak above the 20,000 benchmark. Moreover, five ... bearish territories. Taking into consideration yesterday,s market sentiment, Stock-Callers.com ... morning: Smith & Nephew PLC (NYSE: SNN ...
(Date:2/16/2017)... (NYSE: DVA ) today announced results for the ... Net income attributable to DaVita Inc. for the quarter and ... per share and $880 million, or $4.29 per share, respectively. ... for the quarter and year ended December 31, 2016, excluding ... per share, and $789 million, or $3.85 per share, respectively. ...
(Date:2/16/2017)... Scripts (NASDAQ: ESRX ) was recognized today by Fortune ... Health Care: Pharmacy and Other Services category. "Express Scripts ... Companies," said Tim Wentworth , CEO and President, Express Scripts. ... 26,000 employees to make medicine more affordable and accessible for the ... ...
Breaking Medicine Technology: